Peritoneal Dialysis – Research Article
Malho Guedes A.a,b,c· Calças Marques R.a· Domingos A.T.a· Laranjo C.a· Silva A.P.a,b· Rodrigues A.c,d,eaServiço de Nefrologia, Centro Hospitalar Universitário do Algarve, Porto, Portugal
bAlgarve Biomedical Center, Faro, Portugal
cICBAS – School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal
dServiço de Nefrologia, Centro Hospitalar Universitário do Porto, Porto, Portugal
eUMIB – Unit for Multidisciplinary Research in Biomedicine, Porto, Portugal
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: December 23, 2021
Accepted: June 05, 2022
Published online: August 29, 2022
Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 3
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
AbstractIntroduction: Quantification of peritoneal protein loss (PPL) may be expressed according to a timely collection (24-h measurement or 4-h PET assessment) and as a concentration. The aim of this study was to compare the quantification methods of 24-h and 4-h collections. Methods: This study included 81 prevalent peritoneal dialysis patients. Demographics and clinical and bioelectrical impedance features were registered. PPL was measured (4-h PET and 24-h results) and peritoneal protein clearance was calculated. A linear regression model was performed. Results: Age and continuous ambulatory peritoneal dialysis (compared to cycler) were positively associated with greater PPL on 24-h collections. Neither cardiovascular disease, hypertension, diabetes nor the comorbidity Charlson Index was significantly associated with PPL. There was a consistent univariable relationship with D/P creatinine, whichever sampling method was used. Only 24-h measurements of PPL correlated with body composition variables. In multiple linear regression analysis, D/P creatinine association with PPL stands out. On the other hand, 24-h determinations (in grams or clearance) were associated with overhydration. PET protein quantification was associated with peritoneal creatinine clearance. Discussion/Conclusion: Different methods sign different pathophysiological pathways. PET protein loss quantification should be regarded as a marker of peritoneal membrane intrinsic permeability. Measurements of a 24-h sample might be closer to patients’ clinical status and prognosis, signalizing opportunities for therapy intervention.
© 2022 S. Karger AG, Basel
References Dulaney JT, Hatch FE Jr. Peritoneal dialysis and loss of proteins: a review. Kidney Int. 1984;26(3):253–62. Guedes AM. Peritoneal protein loss, leakage or clearance in peritoneal dialysis, where do we stand? Perit Dial Int. 2019;39(3):201–9. Pérez-Fontán M, Rodríguez-Carmona A, Barreda D, López Muñiz A, Blanco Castro N, García Falcón T. Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients. Nephron Clin Pract. 2010;116(2):c104–13. Sanchez-Villanueva R, Bajo A, del Peso G, Fernandez-Reyes MJ, González E, Romero S et al. Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): a possible new marker of systemic endothelial dysfunction? Nephrol Dial Transplant. 2009;24(3):1009–14. Krediet RT, Zemel D, Imholz AL, Struijk DG. Impact of surface area and permeability on solute clearances. Perit Dial Int. 1994;14(Suppl 3):S70–7. https://www.mdcalc.com/charlson-comorbidity-index-cci. Accessed during the study time period. Bergström J, Heimbürger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int. 1998;18(5):467–73. Ohashi Y, Joki N, Yamazaki K, Kawamura T, Tai R, Oguchi H, et al. Changes in the fluid volume balance between intra- and extracellular water in a sample of Japanese adults aged 15-88 yr old: a cross-sectional study. Am J Physiol. 2018;314(4):F614–22. Xu X, Yang Z, Ma T, Li Z, Chen Y, Zheng Y, et al. The cut-off values of handgrip strength and lean mass index for sarcopenia among patients on peritoneal dialysis. Nutr Metab. 2020;17:84. Balafa O, Halbesma N, Struijk DG, Dekker FW, Krediet RT. Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011;6(3):561–6. Szeto CC, Chow KM, Lam CW, Cheung R, Kwan BC, Chung KY, et al. Peritoneal albumin excretion is a strong predictor of cardiovascular events in peritoneal dialysis patients: a prospective cohort study. Perit Dial Int. 2005;25(5):445–52. Dong J, Chen Y, Luo S, Xu R, Xu Y. Peritoneal protein leakage, systemic inflammation, and peritonitis risk in patients on peritoneal dialysis. Perit Dial Int. 2013;33(3):273–9. Gomes AM, Pérez Fontán M, Rodríguez-Carmona A, López-Muñiz A, Fernández-Villar M, Peteiro-Cartelle J, et al. Peritoneal total protein transport assessed from peritoneal equilibration tests using different dialysate glucose concentrations. Perit Dial Int. 2010;30(5):549–57. Pannekeet MM, Imholz AL, Struijk DG, Koomen GC, Langedijk MJ, Schouten N, et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int. 1995;48(3):866–75. Yoowannakul S, Harris LS, Davenport A. Peritoneal protein losses depend on more than just peritoneal dialysis modality and peritoneal membrane transporter status. Ther Apher Dial. 2018 Apr;22(2):171–7. Yu Z, Tan BK, Dainty S, Mattey DL, Davies SJ. Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant. 2012 Dec;27(12):4437–45. Yu Z, Lambie M, Chess J, Williams A, Do JY, Topley N, et al. Peritoneal protein clearance is a function of local inflammation and membrane area whereas systemic inflammation and comorbidity predict survival of incident peritoneal dialysis patients. Front Physiol. 2019 Feb 18;10:105. Rodriguez-Carmona A, Pérez-Fontan M. Is peritoneal kinetics useful in clinical practice? Against. Nefrologia. 2013;33(3):410–5. Ates K, Ertürk S, Nergisoglu G, Karatan O, Duman N, Erbay B, et al. Sex-dependent variations in peritoneal membrane transport properties in CAPD patients. Nephrol Dial Transplant. 1996 Nov;11(11):2375–6. Fan J, Guo Q, Zhou Q, Yi C, Lin J, Mao H, et al. Gender impact on baseline peritoneal transport properties in incident peritoneal dialysis patients. Int Urol Nephrol. 2019 Nov;51(11):2055–61. Malho Guedes A, Marques R, Domingos AT, Silva AP, Bernardo I, Neves PL, et al. Overhydration may be the missing link between peritoneal protein clearance and mortality. Nephron. 2021 Jun;145(5):474–80. Krediet RT, Yoowannakul S, Harris LS, Davenport A. Relationships between peritoneal protein clearance and parameters of fluid status agree with clinical observations in other diseases that venous congestion increases microvascular protein escape. Perit Dial Int. 2019;39(2):155–62. Article / Publication DetailsFirst-Page Preview
Received: December 23, 2021
Accepted: June 05, 2022
Published online: August 29, 2022
Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 3
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)